Hu Zhou

A multicenter, randomized phase III trial of hetrombopag: a novel thrombopoietin receptor agonist for the treatment of immune thrombocytopenia

Heng Mei, Xiaofan Liu, Yan Li et al. · Journal of Hematology & Oncology · 2021 · 66 citations · Full text

Single VHH-directed BCMA CAR-T cells cause remission of relapsed/refractory multiple myeloma

Lu Han, Jishuai Zhang, Jian Zhou et al. · Leukemia · 2021 · 50 citations · Full text

Hematological Malignancy, Medicine, Immunology +8

Safety and efficacy of CAR-T cell targeting BCMA in patients with multiple myeloma coinfected with chronic hepatitis B virus

Lu Han, Jian Zhou, Keshu Zhou et al. · Journal for ImmunoTherapy of Cancer · 2020 · 44 citations · Full text

Immune thrombocytopenia in the elderly: clinical course in 525 patients from a single center in China

Hu Zhou, Rongfeng Fu, Hongmei Wang et al. · Annals of Hematology · 2012 · 31 citations

Clinical Course, Rheumatology, Thrombosis +14

Efficacy and safety of sovleplenib (HMPL-523) in adult patients with chronic primary immune thrombocytopenia in China (ESLIM-01): a randomised, double-blind, placebo-controlled, phase 3 study

Yu Hu, Xiaofan Liu, Hu Zhou et al. · The Lancet Haematology · 2024 · 24 citations

Thrombopoiesis, Thrombosis, Venous Thrombosis +10